JPMorgan raised the firm’s price target on GSK (GSK) to 1,500 GBp from 1,440 GBp and keeps an Underweight rating on the shares.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GSK:
- Trump Trade: President advocates to close carried interest tax loophole
- GSK sued by Arizona AG for engaging in ‘deceptive’ practices
- GlaxoSmithKline (GSK) Announces Q2 Dividend: Read On for Important Dates
- GSK Earnings Call: Robust Growth Amidst Challenges
- Levi & Korsinsky LLP Reminds Shareholders of a Lead Plaintiff Deadline of April 07, 2025 in GSK plc Lawsuit – GSK